{
    "root": "a1344411-fc64-4233-89ba-e90a1953e150",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Carvedilol",
    "value": "20250301",
    "ingredients": [
        {
            "name": "CARVEDILOL",
            "code": "0K47UL67F2",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_3441"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30563"
        },
        {
            "name": "CROSPOVIDONE, UNSPECIFIED",
            "code": "2S7830E561"
        },
        {
            "name": "HYPROMELLOSE, UNSPECIFIED",
            "code": "3NXW29V3WO",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11075"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17716"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14158"
        },
        {
            "name": "POLYETHYLENE GLYCOL, UNSPECIFIED",
            "code": "3WJQ0SDW1A",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "SODIUM CITRATE, UNSPECIFIED FORM",
            "code": "1Q73Q2JULR",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_53258"
        },
        {
            "name": "SUCROSE",
            "code": "C151H8M554",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17992"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        }
    ],
    "indications": {
        "text": "carvedilol tablet alpha/beta-adrenergic blocking agent indicated treatment : \u2022 mild severe chronic heart failure ( 1.1 ) \u2022 left ventricular dysfunction following myocardial infarction clinically stable patients ( 1.2 ) \u2022 hypertension ( 1.3 )",
        "doid_entities": [
            {
                "text": "myocardial infarction (DOID:5844)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_5844"
            },
            {
                "text": "hypertension (DOID:10763)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10763"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "carvedilol tablet taken food slow rate absorption reduce incidence orthostatic effects .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": null,
    "adverseReactions": "carvedilol tablet contraindicated following conditions : \u2022 bronchial asthma related bronchospastic conditions . deaths status asthmaticus reported following single doses carvedilol tablet . \u2022second- third-degree av block \u2022sick sinus syndrome \u2022severe bradycardia ( unless permanent pacemaker place ) \u2022patients cardiogenic shock decompensated heart failure requiring intravenous inotropic therapy . patients first weaned intravenous therapy initiating carvedilol tablet . \u2022patients severe hepatic impairment \u2022patients history serious hypersensitivity reaction ( e.g . , stevens-johnson syndrome , anaphylactic reaction , angioedema ) component medication medications containing carvedilol .",
    "indications_original": "Carvedilol Tablet is an alpha/beta-adrenergic blocking agent indicated for the treatment of: \u2022 Mild to severe chronic heart failure ( 1.1 ) \u2022 Left ventricular dysfunction following myocardial infarction in clinically stable patients ( 1.2 ) \u2022 Hypertension ( 1.3 )",
    "contraindications_original": "Carvedilol Tablet should be taken with food to slow the rate of absorption and reduce the incidence of orthostatic effects.",
    "adverseReactions_original": "Carvedilol Tablet is contraindicated in the following conditions:\n                  \n                     \n                        \u2022\n                        Bronchial asthma or related bronchospastic conditions. Deaths from status asthmaticus have been reported following single doses of Carvedilol Tablet.\n                     \n                     \n                        \u2022Second- or third-degree AV block\n                     \n                        \u2022Sick sinus syndrome\n                     \n                        \u2022Severe bradycardia (unless a permanent pacemaker is in place)\n                     \n                        \u2022Patients with cardiogenic shock or who have decompensated heart failure requiring the use of intravenous inotropic therapy. Such patients should first be weaned from intravenous therapy before initiating Carvedilol Tablet.\n                     \n                        \u2022Patients with severe hepatic impairment\n                     \n                        \u2022Patients with a history of a serious hypersensitivity reaction (e.g., Stevens-Johnson syndrome, anaphylactic reaction, angioedema) to any component of this medication or other medications containing carvedilol.",
    "drug": [
        {
            "name": "Carvedilol",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_3441"
        }
    ]
}